St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
SJW has the greatest evidence of herbal medicine efficacy in treating MDD. In treating anxiety, kava has the greatest evidence of efficacy. As comorbidity of MDD and anxiety commonly occurs, it is conceivable that a combination of an established antidepressant agent such as SJW and an established anxiolytic agent such as kava may effectively treat MDD presenting with comorbid anxiety. It is possible that a beneficial synergistic effect may also occur between SJW and kava, improving the treatment outcomes in MDD with comorbid anxiety, than by the individual substances alone. Determination of this is not addressed in this study due to limitations of time and resources. The determination of the strength of the SJW-kava combination will be ascertained by comparing similar trials using SJW and kava mono-therapy in addressing MDD and GAD.
The hypothesis is that a combination of SJW and kava will reduce MDD occurring with comorbid anxiety more than placebo.
Depressive Disorder, Major
Drug: Herbal medicine (St. John's wort and Kava)
|Study Design:||Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety|
Please refer to this study by its ClinicalTrials.gov identifier: NCT00451516
|Brisbane, Queensland, Australia, 4006|
|Principal Investigator:||Jerome Sarris, BHSc||The University of Queensland|